Neurogene
Natasha Patel's work experience begins in 2015 as a Guest Relations Coordinator at Six Flags Discovery Kingdom. Natasha then worked as a Toxicology Lab Assistant at Redwood Toxicology Laboratory for a few months in 2015. From 2016 to 2018, they were a Manufacturing Associate at BioMarin Pharmaceutical Inc. In 2018, they joined Boehringer Ingelheim as a Scientist I, where they focused on optimizing upstream process development and managing data representation. In 2019, they became an Associate Scientist at FUJIFILM Diosynth Biotechnologies, where they worked on developing, optimizing, and scaling-up cell platforms and conducting cell line development and viral harvest studies. Most recently, starting in October 2020, Natasha has been working as a Scientist in Upstream Process Development at Neurogene Inc.
Natasha Patel pursued their Bachelor's Degree in Microbiology and Immunology from the University of California, Merced, from 2011 to 2015.
This person is not in any offices
Neurogene
Neurogene was founded to bring life-changing medicines to patients and families affected by rare neurological disorders. We partner with leading academic researchers, patient advocacy organizations and caregivers to bring to patients therapies that address the underlying genetic cause of a broad spectrum of neurological diseases where no effective treatment options exist today. Our lead programs use AAV-based gene therapy technology to deliver a normal gene to patients with a dysfunctional gene. Neurogene is also investing in novel technology to develop treatments for diseases not well served by gene therapy.